China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review

November 2021 | 41 pages | ID: CFDECB2B5C77EN
GlobalData

Abstracts

China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China NT Pharma Group Co Ltd (NT Pharma) is a technology-based and scientific pharmaceutical company, which researches, develops, manufactures and distributes branded and generic pharmaceuticals. The company also promotes and distributes drugs manufactured by third parties. It develops drugs for indications such as cancer; central nervous system disorders; orthopedics; hepatopathy and respiratory disorders. NT Pharma’s branded products include Xi Di Ke for the treatment of various cancers; Miacalcic for bone pain; Shusi, an antipsychotic drug; Zhuo’ao, a respiratory drug, and Songzhi Wan, a traditional Chinese medicine for the treatment of Hepatitis C. The company operates three production bases for chemical drugs, traditional Chinese medicine and bio-chemical drugs through its subsidiaries, Suzhou First, Jiangsu Biopharma and Changsha Pharma. NT Pharma is headquartered in Sheung Wan, Hong Kong.

China NT Pharma Group Co Ltd Key Recent Developments

Aug 28,2020: China NT Pharma: Interim results announcement for the six months ended 30 JUNE 2020
Aug 14,2020: China NT Pharma : Supplemental announcement to the annual report for the year ended 31 December 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

China NT Pharma Group Co Ltd - Key Facts
China NT Pharma Group Co Ltd - Key Employees
China NT Pharma Group Co Ltd - Key Employee Biographies
China NT Pharma Group Co Ltd - Major Products and Services
China NT Pharma Group Co Ltd - History
China NT Pharma Group Co Ltd - Company Statement
China NT Pharma Group Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
China NT Pharma Group Co Ltd - Business Description
Business Segment: Proprietary Products Production and Sales and Promotion
Overview
Performance
Geographical Segment: PRC
Performance
R&D Overview
China NT Pharma Group Co Ltd - Corporate Strategy
China NT Pharma Group Co Ltd - SWOT Analysis
SWOT Analysis - Overview
China NT Pharma Group Co Ltd - Strengths
China NT Pharma Group Co Ltd - Weaknesses
China NT Pharma Group Co Ltd - Opportunities
China NT Pharma Group Co Ltd - Threats
China NT Pharma Group Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
China NT Pharma Group Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 28, 2020: China NT Pharma: Interim results announcement for the six months ended 30 JUNE 2020
Aug 14, 2020: China NT Pharma : Supplemental announcement to the annual report for the year ended 31 December 2019

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

China NT Pharma Group Co Ltd, Key Facts
China NT Pharma Group Co Ltd, Key Employees
China NT Pharma Group Co Ltd, Key Employee Biographies
China NT Pharma Group Co Ltd, Major Products and Services
China NT Pharma Group Co Ltd, History
China NT Pharma Group Co Ltd, Other Locations
China NT Pharma Group Co Ltd, Subsidiaries
China NT Pharma Group Co Ltd, Key Competitors
China NT Pharma Group Co Ltd, Ratios based on current share price
China NT Pharma Group Co Ltd, Annual Ratios
China NT Pharma Group Co Ltd, Annual Ratios (Cont...1)
China NT Pharma Group Co Ltd, Annual Ratios (Cont...2)
China NT Pharma Group Co Ltd, Interim Ratios
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
China NT Pharma Group Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

China NT Pharma Group Co Ltd, Performance Chart (2016 - 2020)
China NT Pharma Group Co Ltd, Ratio Charts
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021